Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 2/20 | 0.60 |
| ▸ | CDC25A | P30304 | 1/20 | 0.52 |
| ▸ | CDC25C | P30307 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28989655 | 0.87 | ALDH1A1 (0.50) | CDC25BCDC25ACDC25CALDH1A1KDM4E | |
| SCHEMBL27798501 | 0.85 | ALDH1A1 (0.59) | CDC25BCDC25ACDC25CALDH1A1KDM4E | |
| SCHEMBL697232 | 0.84 | CDC25B (0.63) | CDC25BCDC25ACDC25CALDH1A1KDM4E | |
| SCHEMBL2777501 | 0.83 | CNR2 (0.47) | CDC25BALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL22062251 | 0.83 | CDC25B (0.61) | CDC25BCDC25ACDC25CALDH1A1KDM4E | |
| SCHEMBL3794319 | 0.82 | PLK1 (0.54) | CDC25BALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL2777499 | 0.82 | NR4A1 (0.45) | CDC25BALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL9696983 | 0.82 | CYP3A4 (0.53) | CDC25BALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL27648071 | 0.82 | NR4A1 (0.45) | CDC25BALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL28989610 | 0.81 | KMT2A (0.48) | CDC25BCDC25ACDC25CALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050069637-A1 | Method for manufacturing planar optical waveguide | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2005-03-31 | — | — | US | claimed |
| CN-116981758-A | Thermally responsive brush polymers having a copolymer backbone and copolymer arms | 英菲诺姆国际有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-115989251-A | Composition comprising an additive having polycyclic aromatic groups | 伊英克公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-112367983-A | 1,4 substituted isoquinoline inhibitors of KEAP1/NRF2 protein-protein interaction | 伊利诺伊大学评议会 | 2021-02-12 | — | — | CN | disclosed |
| EP-1791901-B1 | STABILIZATION OF ORGANIC MATERIALS | BASF SE (DE) | 2018-03-28 | — | — | EP | disclosed |
| EP-1791901-B1 | STABILIZATION OF ORGANIC MATERIALS | BASF SE (DE) | 2018-03-28 | — | — | EP | disclosed |
| US-9051448-B2 | Stabilization of organic materials | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051448-B2 | Stabilization of organic materials | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051448-B2 | Stabilization of organic materials | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20080269382-A1 | Stabilization of Organic Materials | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
| WO-2001021600-A1 | CASPASE INHIBITOR | LG CHEM INVESTMENT LTD. (KR) | 2001-03-29 | — | — | WO | disclosed |
| WO-2001021599-A1 | CASPASE INHIBITOR | LG CHEMICAL LTD. (KR) | 2001-03-29 | — | — | WO | disclosed |
| US-6162822-A | Bisimide compounds | ADIR ET COMPAGNIE (FR) | 2000-12-19 | — | — | US | disclosed |
| WO-2000061539-A1 | 3-BICYCLOARYL-2-AMINOMETHYL BICYCLOALKANES AS SEROTONINE REUPTAKE INHIBITORS | ELI LILLY AND COMPANY LIMITED (GB) | 2000-10-19 | — | — | WO | disclosed |
| US-6005116-A | HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA | SANKYO COMPANY, LIMITED (JP) | 1999-12-21 | — | — | US | disclosed |
| US-5854273-A | Bisimide compounds | ADIR ET COMPAGNIE (FR) | 1998-12-29 | — | — | US | disclosed |
| EP-0885891-A1 | ISOXAZOLE DERIVATIVES | SANKYO COMPANY LIMITED (JP) | 1998-12-23 | — | — | EP | disclosed |
| EP-0040177-B1 | PROCESS FOR THE PREPARATION OF BENZENE OR NAPHTHALENE ALKENYL CARBOXYLIC ACID DERIVATIVES | CIBA-GEIGY AG (CH) | 1983-07-20 | — | — | EP | disclosed |
| US-4335054-A | Process for the preparation of alkenylbenzenecarboxylic acid derivatives and alkenylnaphthalenecarboxylic acid derivatives | CIBA-GEIGY CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| WO-1980001978-A1 | SOLID STATE DEVICES BY DIFFERENTIAL PLASMA ETCHING OF RESISTS | WESTERN ELECTRIC CO (US) | 1980-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269382-A1 | Stabilization of Organic Materials | LPO, PPOX, HMOX1 | CDC25B 1105/4885CDC25A 309/4885CDC25C 1070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.